1.
Time Investment in Drug Supply Problems by Flemish Community Pharmacies
2.
Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking
Table1_Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking.DOCX
Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case study
3.
4.
The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis
5.
datasheet1_Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis.docx
6.
7.
8.
9.
Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study.
Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium
DataSheet1_Implementing the EU HTA regulation: Insights from semi-structured interviews on patient expectations, Belgian and European institutional perspectives, and industry outlo...